Beyond Traditional Testing: Emerging Approaches to Cancer Triage and Precision Diagnostics
The future of cancer diagnostics is moving beyond traditional testing.
Ngaio Diagnostics is proud to be contributing to this important conversation at the NZIMLS Annual Scientific Meeting 2026.
Our Head of Clinical Diagnostics, Dr Mak Sarwar, will present: Beyond Traditional Testing: Emerging Approaches to Cancer Triage and Precision Diagnostics
This presentation explores how advances in molecular biomarkers, digital pathology, artificial intelligence, and computational diagnostics are helping reshape cancer care. Using real-world examples, the session will discuss how integrated diagnostic approaches can:
- Improve patient stratification and risk assessment
- Support more informed clinical decision making
- Enable more personalised treatment selection
- Strengthen diagnostic pathways through innovative molecular and AI-enabled technologies
At Ngaio Diagnostics, we believe the future of pathology lies not only in delivering high-quality diagnostic products, but also in introducing innovative technologies that address unmet clinical needs and help laboratories prepare for the next generation of precision medicine.
NZIMLS Annual Scientific Meeting 2026
Thursday, 20 August 2026
3:30–4:00 pm | Molecular Stream
If you are attending the conference, we invite you to join us for what promises to be an insightful discussion on emerging diagnostic pathways and the future of precision cancer diagnostics.
We look forward to connecting with colleagues across New Zealand and sharing ideas that can help advance patient care.